{"title":"Racial and ethnic disparities in financial toxicity among cancer survivors: implications for equity in survivorship care.","authors":"Noah Hammarlund, Molly Jacobs","doi":"10.1007/s11764-025-01817-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Financial toxicity (FT) represents a significant challenge for cancer survivors, disproportionately affecting racial and ethnic minorities. This study examines income and wealth changes among cancer survivors and explores the implications for survivorship care equity.</p><p><strong>Methods: </strong>We analyzed longitudinal cohort data from the Medical Expenditure Panel Survey (2018-2021) to examine how cancer diagnoses (prostate, colon, lung, or breast cancer) affect income and wealth. Fixed effects regression controlled for unobserved individual differences, isolating the impact of cancer. We used interaction terms to explore racial and ethnic disparities and applied Heckman models to test the robustness of the results to potential selection bias.</p><p><strong>Results: </strong>Of the 5409 respondents, 229 (4.23%) reported a diagnosis of one of the targeted cancers. Cancer diagnosis was associated with a 14.44 percentage point reduction in income and a 15.94 percentage point reduction in wealth. Hispanic cancer survivors saw a 42.27 percentage point reduction in income and 36.83 percentage points in wealth, while Black cancer survivors saw reductions of 20.99 percentage points in income and 19.98 percentage points in wealth. These disparities persisted across different model specifications.</p><p><strong>Conclusion: </strong>This study provides robust estimates of the financial impact of cancer, revealing significant and disproportionate financial burdens among Black and Hispanic survivors. These findings underscore the need for integrating financial health assessments into survivorship care to address inequities and improve quality of life.</p><p><strong>Implications for cancer survivors: </strong>Our findings indicate that cancer is associated with significant reductions in income and wealth, with disproportionate burdens observed among Black and Hispanic survivors. These results highlight the need for greater attention to financial well-being in survivorship care, especially for systemically marginalized groups.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Survivorship","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11764-025-01817-1","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Financial toxicity (FT) represents a significant challenge for cancer survivors, disproportionately affecting racial and ethnic minorities. This study examines income and wealth changes among cancer survivors and explores the implications for survivorship care equity.
Methods: We analyzed longitudinal cohort data from the Medical Expenditure Panel Survey (2018-2021) to examine how cancer diagnoses (prostate, colon, lung, or breast cancer) affect income and wealth. Fixed effects regression controlled for unobserved individual differences, isolating the impact of cancer. We used interaction terms to explore racial and ethnic disparities and applied Heckman models to test the robustness of the results to potential selection bias.
Results: Of the 5409 respondents, 229 (4.23%) reported a diagnosis of one of the targeted cancers. Cancer diagnosis was associated with a 14.44 percentage point reduction in income and a 15.94 percentage point reduction in wealth. Hispanic cancer survivors saw a 42.27 percentage point reduction in income and 36.83 percentage points in wealth, while Black cancer survivors saw reductions of 20.99 percentage points in income and 19.98 percentage points in wealth. These disparities persisted across different model specifications.
Conclusion: This study provides robust estimates of the financial impact of cancer, revealing significant and disproportionate financial burdens among Black and Hispanic survivors. These findings underscore the need for integrating financial health assessments into survivorship care to address inequities and improve quality of life.
Implications for cancer survivors: Our findings indicate that cancer is associated with significant reductions in income and wealth, with disproportionate burdens observed among Black and Hispanic survivors. These results highlight the need for greater attention to financial well-being in survivorship care, especially for systemically marginalized groups.
期刊介绍:
Cancer survivorship is a worldwide concern. The aim of this multidisciplinary journal is to provide a global forum for new knowledge related to cancer survivorship. The journal publishes peer-reviewed papers relevant to improving the understanding, prevention, and management of the multiple areas related to cancer survivorship that can affect quality of care, access to care, longevity, and quality of life. It is a forum for research on humans (both laboratory and clinical), clinical studies, systematic and meta-analytic literature reviews, policy studies, and in rare situations case studies as long as they provide a new observation that should be followed up on to improve outcomes related to cancer survivors. Published articles represent a broad range of fields including oncology, primary care, physical medicine and rehabilitation, many other medical and nursing specialties, nursing, health services research, physical and occupational therapy, public health, behavioral medicine, psychology, social work, evidence-based policy, health economics, biobehavioral mechanisms, and qualitative analyses. The journal focuses exclusively on adult cancer survivors, young adult cancer survivors, and childhood cancer survivors who are young adults. Submissions must target those diagnosed with and treated for cancer.